Race is on Between Ebola and Researchers in DR Congo

Part of the response to the current outbreak has been to try out new drug regimes. As such, research is playing a critical role as efforts are made to establish their efficacy. But testing new vaccines is an arduous and time consuming process. It's also hard in the case of Ebola because there are a few different strains of the virus writes The Conversation Africa.

The Government of Democratic Republic of the Congo, with the support of WHO and partners, carried out a vaccination campaign in high-risk populations against Ebola virus disease in affected health zones.

InFocus

See What Everyone is Watching